Sinochem contributed to a total of $443m series B and pre-IPO funding for SolarSpace while Pernod Ricard took part in a $110m round for Fever.

Google invested $300m in AI technology developer Anthropic while robotics unicorn UBTech filed for a Hong Kong IPO.

Alkem participated in a $50m round for its Enzene spinoff while Schlumberger took part in The Exploration Company’s $43.6m series A.

Telefónica participated in a $136m round for Raylo while Novartis helped Alto Neuroscience hike its series B to $60m.

BMW took part in Our Next Energy’s $300m series B round while Animoca Brands contributed to Colossal Biosciences’ $150m series B.

LenDenClub invested in six Indian fintech companies through its venture scheme while Alphabet participated in clinical trial management startup Paradigm’s $203m series A round.

UPMC co-led Smile Digital Health’s $30m series B round while four pharmaceutical firms participated in iVexSol’s $23.8m series A.

ArcelorMittal led the first tranche of Boston Metal’s $120m series C round while GV helped Google spinoff Osmo raise $60m.

ADP took part in Welcome to the Jungle’s $54m series C round while Smith+Nephew and DSM contributed to Miach Orthopaedics’ $40m series B.

Eni and Saudi Aramco were part of Pasqal’s $109m series B round while Boston Scientific and GSK helped SetPoint Medical pull in $80m.